DS
FURX

David Shaw’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

David Shaw’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-804,024
Closed -$85.4M – 4689
2014
Q2 		$85.4M Buy
804,024
+783,036
+3,731% +$76.8M 0.12% 199
2014
Q1 		$1.83M Sell
20,988
-403
-2% -$31.1K ﹤0.01% 2484
2013
Q4 		$899K Sell
21,391
-5,723
-21% -$235K ﹤0.01% 3269
2013
Q3 		$1.19M Sell
27,114
-19,834
-42% -$821K ﹤0.01% 2880
2013
Q2 		$1.6M Buy
+46,948
New +$1.65M ﹤0.01% 2336

David Shaw's FURX Position: Q3 2014 in Review

David Shaw sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 804,024 shares — an estimated $85.4M sold.

David Shaw first reported a position in FURX in Q2 2013 and held it in 5 quarters. The position peaked at $85.4M in Q2 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

  • David Shaw reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • David Shaw sold 804,024 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $85.4M.
  • David Shaw first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 5 quarters.
  • David Shaw's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $85.4M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on D.E. Shaw & Co's 13F filing for Q3 2014, filed 14 Nov 2014.